The coronavirus epidemic spread to many countries of the world after the city of Wuhan, where it originated, causing millions of cases and loss of more than 193 thousand lives. As many scientists are working day and night to combat the virus, this time new news came from the United States. Researchers from NASA announced that they have developed a breathing apparatus for the treatment of patients suffering from coronavirus. Let’s also mention that NASA expects approval from the United States Food and Drug Administration (FDA) for the device, which is said to treat coronavirus patients in just 37 days. This machine, which the space agency is very ambitious about the treatment, has passed a critical test earlier this week and it is said that approval will come soon. It can be used all over the world: The device produced by Jet Propulsion Laboratory (JPL) engineers, known as NASA’s research and development center, was named VITAL. The name given means ‘locally accessible respirator intervention technology’. “We are experts in spacecraft production, not just in medical device production, but also excellent engineering, rigorous testing and rapid prototyping are some of our specialties,” JPL’s executive director Michael Watkins explains. The researchers also underline that the new breathing apparatus developed compared to the standard breathing apparatus has fewer parts. This situation stands out as a factor that facilitates device maintenance. It is also stated that the new devices are suitable for use in field hospitals. It is also stated by NASA’s respiratory equipment that it will be very useful both for the USA and the world. What does the breathing apparatus do? The breathing apparatus, a device familiar to healthcare workers, is known as a machine designed to provide mechanical ventilation by moving the breath into and out of the lungs and to breathe patients who are unable to breathe physically or inadequate breathing. Breathing apparatus is mainly used in intensive care units.
